These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17828300)

  • 21. p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas.
    Pagnano KB; Vassallo J; Lorand-Metze I; Costa FF; Saad ST
    Am J Hematol; 2001 Jun; 67(2):84-92. PubMed ID: 11343379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to Apoptosis.
    Grabow S; Delbridge AR; Aubrey BJ; Vandenberg CJ; Strasser A
    Cell Rep; 2016 Mar; 14(10):2337-47. PubMed ID: 26947081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis.
    Gramling MW; Eischen CM
    Cell Death Differ; 2012 Jul; 19(7):1220-7. PubMed ID: 22301919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Msh2-dependent DNA repair mitigates a unique susceptibility of B cell progenitors to c-Myc-induced lymphomas.
    Nepal RM; Tong L; Kolaj B; Edelmann W; Martin A
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18698-703. PubMed ID: 19837692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.
    Yang HL; Dong YB; Elliott MJ; Liu TJ; Atienza C; Stilwell A; McMasters KM
    Clin Cancer Res; 1999 Aug; 5(8):2242-50. PubMed ID: 10473112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development.
    Terzian T; Wang Y; Van Pelt CS; Box NF; Travis EL; Lozano G
    Mol Cell Biol; 2007 Aug; 27(15):5479-85. PubMed ID: 17526734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis.
    Hagiyama H; Adachi T; Yoshida T; Nomura T; Miyasaka N; Honjo T; Tsubata T
    Oncogene; 1999 Jul; 18(28):4091-8. PubMed ID: 10435590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma.
    Drakos E; Thomaides A; Medeiros LJ; Li J; Leventaki V; Konopleva M; Andreeff M; Rassidakis GZ
    Clin Cancer Res; 2007 Jun; 13(11):3380-7. PubMed ID: 17545546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MYC-driven malignant transformation of mature murine B cells requires inhibition of both intrinsic apoptosis and p53 activity.
    Högstrand K; Grandien A
    Eur J Immunol; 2019 Mar; 49(3):375-385. PubMed ID: 30281155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor promotion by Mdm2 splice variants unable to bind p53.
    Fridman JS; Hernando E; Hemann MT; de Stanchina E; Cordon-Cardo C; Lowe SW
    Cancer Res; 2003 Sep; 63(18):5703-6. PubMed ID: 14522887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis.
    Post SM; Quintás-Cardama A; Terzian T; Smith C; Eischen CM; Lozano G
    Oncogene; 2010 Mar; 29(9):1260-9. PubMed ID: 19935700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice.
    Vecchio E; Fiume G; Mignogna C; Iaccino E; Mimmi S; Maisano D; Trapasso F; Quinto I
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pim1 and Myc reversibly transform murine precursor B lymphocytes but not mature B lymphocytes.
    Bouquet C; Melchers F
    Eur J Immunol; 2012 Feb; 42(2):522-32. PubMed ID: 22101984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.
    Kelly PN; Grabow S; Delbridge AR; Strasser A; Adams JM
    Blood; 2011 Dec; 118(24):6380-6. PubMed ID: 21998213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3.
    Petrenko O; Li J; Cimica V; Mena-Taboada P; Shin HY; D'Amico S; Reich NC
    PLoS One; 2021; 16(3):e0247394. PubMed ID: 33651821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.
    Nilsson LM; Keller UB; Yang C; Nilsson JA; Cleveland JL; Roussel MF
    Oncogene; 2007 May; 26(20):2833-9. PubMed ID: 17099725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mdm2 affects genome stability independent of p53.
    Bouska A; Eischen CM
    Cancer Res; 2009 Mar; 69(5):1697-701. PubMed ID: 19244108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
    Nepal RM; Zaheen A; Basit W; Li L; Berger SA; Martin A
    Oncogene; 2008 Aug; 27(34):4752-6. PubMed ID: 18408759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
    Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
    Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
    Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ; Anderson CW; Appella E; Bulavin DV
    J Exp Med; 2006 Dec; 203(13):2793-9. PubMed ID: 17158963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.